Department of Surgery, Canisius Wilhelmina Ziekenhuis, Weg door Jonkerbosch 100, Nijmegen, The Netherlands.
Breast. 2011 Jun;20(3):229-32. doi: 10.1016/j.breast.2011.01.002. Epub 2011 Jan 28.
We aimed to retrospectively assess (1) the conclusiveness of breast fine needle aspiration (FNA) in a histologically confirmed population and (2) the clinical and radiologic determinants of a conclusive diagnosis. Aspirates were diagnosed as inadequate, benign, atypical, suspicious or malignant. We defined a conclusive FNA diagnosis as 'benign' in histologically benign lesions and as 'malignant' in histologically malignant lesions. In 2419 breast lesions, the proportion of conclusive diagnoses was 46.1% (95% confidence interval, 42.0-50.2%) in histologically benign lesions (n = 571) and 81.6% (95% confidence interval, 79.8%-83.4%) in histologically malignant lesions (n = 1848). On multivariate analysis, factors associated with a conclusive preoperative diagnosis included tumour diameter of 2-2.9 cm (P < 0.001), malignant histology (P < 0.001) and the pathologist examining the aspirate (P = 0.02). Breast FNA has to be utilised selectively in the routine work-up of breast lesions. In suspicious lesions of large size, FNA may still be used to obtain a quick confirmation of malignancy.
(1) 在组织学确诊的人群中,乳腺细针穿刺(FNA)的结论性;(2) 诊断明确的临床和影像学决定因素。穿刺标本的诊断为不充分、良性、非典型、可疑或恶性。我们将明确的 FNA 诊断定义为:组织学良性病变中的“良性”,组织学恶性病变中的“恶性”。在 2419 个乳腺病变中,组织学良性病变(n=571)的明确诊断比例为 46.1%(95%置信区间,42.0-50.2%),组织学恶性病变(n=1848)的明确诊断比例为 81.6%(95%置信区间,79.8%-83.4%)。多变量分析显示,与明确术前诊断相关的因素包括肿瘤直径 2-2.9cm(P<0.001)、恶性组织学(P<0.001)和检查穿刺标本的病理学家(P=0.02)。乳腺 FNA 在乳腺病变的常规检查中必须有选择性地使用。在大尺寸的可疑病变中,FNA 仍可用于快速确认恶性肿瘤。